In vitro activity of baicalein against Candida albicans biofilms

International Journal of Antimicrobial Agents

Volumn 32, Issue 1, 2008, Pages 73-77

  Cao, YingYing ^a   Dai, BaoDi ^b   Wang, Yan ^a   Huang, Shan ^a   Xu, YongGang ^a   Cao, YongBing ^a   Gao, PingHui ^a   Zhu, ZhenYu ^a   Jiang, YuanYing ^a,b  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Baicalein; Biofilm; Candida albicans; Cell surface hydrophobicity

Indexed keywords

BAICALEIN;

ARTICLE; BIOFILM; CANDIDA ALBICANS; CELL SURFACE; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; FUNGUS GROWTH; HYDROPHOBICITY; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION;

ANTIFUNGAL AGENTS; BIOFILMS; CANDIDA ALBICANS; DOSE-RESPONSE RELATIONSHIP, DRUG; FLAVANONES; FUNGAL PROTEINS; GENE EXPRESSION PROFILING; MICROSCOPY, CONFOCAL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 44949147073     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2008.01.026     Document Type: Article

References (34)

1. O'Toole G., Kaplan H.B., and Kolter R. Biofilm formation as microbial development. Annu Rev Microbiol 54 (2000) 49-79
2. Anaissie E.J., Rex J.H., Uzun O., and Vartivarian S. Predictors of adverse outcome in cancer patients with candidemia. Am J Med 104 (1998) 238-245
3. Kuhn D.M., Chandra J., Mukherjee P.K., and Ghannoum M.A. Comparison of biofilms formed by Candida albicans and Candida parapsilosis on bioprosthetic surfaces. Infect Immun 70 (2002) 878-888
4. Nguyen M.H., Peacock Jr. J.E., Tanner D.C., Morris A.J., Nguyen M.L., Snydman D.R., et al. Therapeutic approaches in patients with candidemia. Evaluation in a multicenter, prospective, observational study. Arch Intern Med 155 (1995) 2429-2435
5. Nicastri E., Petrosiillo N., Viale P., and Ippolito G. Catheter-related bloodstream infections in HIV-infected patients. Ann NY Acad Sci 946 (2001) 274-290
6. Costerton J.W., Stewart P.S., and Greenberg E.P. Bacterial biofilms: a common cause of persistent infections. Science 284 (1999) 1318-1322
7. Davey M.E., and O'Toole G.A. Microbial biofilms: from ecology to molecular genetics. Microbiol Mol Biol Rev 64 (2000) 847-867
8. Chandra J., Mukherjee P.K., Leidich S.D., Faddoul F.F., Hoyer L.L., Douglas L.J., et al. Antifungal resistance of candidal biofilms formed on denture acrylic in vitro. J Dent Res 80 (2001) 903-908
9. Ramage G., VandeWalle K., Wickes B.L., and Lopez-Ribot J.L. Characteristics of biofilm formation by Candida albicans. Rev Iberoam Micol 18 (2001) 163-170
10. Ono K., Nakane H., Fukushima M., Chermann J.C., and Barré-Sinoussi F. Differential inhibitory effects of various flavonoids on the activities of reverse transcriptase and cellular DNA and RNA polymerases. Eur J Biochem 5 (1990) 469-476
11. van Leyen K., Kim H.Y., Lee S.R., Jin G., Arai K., and Lo E.H. Baicalein and 12/15-lipoxygenase in the ischemic brain. Stroke 37 (2006) 3014-3018
12. Lapchak P.A., Maher P., Schubert D., and Zivin J.A. Baicalein, an antioxidant 12/15-lipoxygenase inhibitor improves clinical rating scores following multiple infarct embolic strokes. Neuroscience 150 (2007) 585-591
13. Lin H.Y., Shen S.C., Lin C.W., Yang L.Y., and Chen Y.C. Baicalein inhibition of hydrogen peroxide-induced apoptosis via ROS-dependent heme oxygenase 1 gene expression. Biochim Biophys Acta 1773 (2007) 1073-1086
14. Chang W.T., Shao Z.H., Yin J.J., Mehendale S., Wang C.Z., Qin Y., et al. Comparative effects of flavonoids on oxidant scavenging and ischemia-reperfusion injury in cardiomyocytes. Eur J Pharmacol 566 (2007) 58-66
15. Ishige K., Schubert D., and Sagara Y. Flavonoids protect neuronal cells from oxidative stress by three distinct mechanisms. Free Radic Biol Med 30 (2001) 433-446
16. Chang P.C., Li H.Y., Tang H.J., Liu J.W., Wang J.J., and Chuang Y.C. In vitro synergy of baicalein and gentamicin against vancomycin-resistant Enterococcus. J Microbiol Immunol Infect 40 (2007) 56-61
17. Wu J.A., Attele A.S., Zhang L., and Yuan C.S. Anti-HIV activity of medicinal herbs: usage and potential development. Am J Chin Med 29 (2001) 69-81
18. Yang D., Hu H., and Huang S. Study on the inhibitory activity, in vitro, of baicalein and baicalin against skin fungi and bacteria. Zhong Yao Cai 23 (2000) 272-274 [in Chinese]
19. Klotz S.A., Drutz D.J., and Zajic J.E. Factors governing adherence of Candida species to plastic surfaces. Infect Immun 50 (1985) 97-101
20. Wang Y., Cao Y.Y., Jia X.M., Cao Y.B., Gao P.H., Fu X.P., et al. Cap1p is involved in multiple pathways of oxidative stress response in Candida albicans. Free Radic Biol Med 40 (2006) 1201-1209
21. Bachmann S.P., VandeWalle K., Ramage G., Patterson T.F., Wickes B.L., Graybill J.R., et al. In vitro activity of caspofungin against Candida albicans biofilms. Antimicrob Agents Chemother 46 (2002) 3591-3596
22. Cocuaud C., Rodier M.H., Daniault G., and Imbert C. Anti-metabolic activity of caspofungin against Candida albicans and Candida parapsilosis biofilms. J Antimicrob Chemother 56 (2005) 507-512
23. Kuhn D.M., George T., Chandra J., Mukherjee P.K., and Ghannoum M.A. Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins. Antimicrob Agents Chemother 46 (2002) 1773-1780
24. Di Carlo G., Mascolo N., Izzo A.A., and Capasso F. Flavonoids: old and new aspects of a class of natural therapeutic drugs. Life Sci 65 (1999) 337-353
25. Lin C.C., and Shieh D.E. The anti-inflammatory activity of Scutellaria rivularis extracts and its active components, baicalin, baicalein and wogonin. Am J Chin Med 24 (1996) 31-36
26. Shao Z.H., Vanden Hoek T.L., Qin Y., Becker L.B., Schumacker P.T., Li C.Q., et al. Baicalein attenuates oxidant stress in cardiomyocytes. Am J Physiol Heart Circ Physiol 282 (2002) 999-1006
27. Baillie G.S., and Douglas L.J. Candida biofilms and their susceptibility to antifungal agents. Methods Enzymol 310 (1999) 644-656
28. Chandra J., Kuhn D.M., Mukherjee P.K., Hoyer L.L., McCormick T., and Ghannoum M.A. Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance. J Bacteriol 183 (2001) 5385-5394
29. el-Azizi M., and Khardori N. Factors influencing adherence of Candida spp. to host tissues and plastic surfaces. Indian J Exp Biol 37 (1999) 941-951
30. Reynolds T.B., and Fink G.R. Bakers' yeast, a model for fungal biofilm formation. Science 291 (2001) 878-881
31. Samaranayake Y.H., Wu P.C., Samaranayake L.P., and So M. Relationship between the cell surface hydrophobicity and adherence of Candida krusei and Candida albicans to epithelia and denture acrylic surfaces. APMIS 103 (1995) 707-713
32. Silva T.M., Glee P.M., and Hazen K.C. Influence of cell surface hydrophobicity on attachment of Candida albicans to extracellular matrix proteins. J Med Vet Mycol 33 (1995) 117-122
33. Li X., Yan Z., and Xu J. Quantitative variation of biofilms among strains in natural populations of Candida albicans. Microbiology 149 (2003) 353-362
34. Singleton D.R., Masuoka J., and Hazen K.C. Cloning and analysis of a Candida albicans gene that affects cell surface hydrophobicity. J Bacteriol 183 (2001) 3582-3588